BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND NPM1, NPM, 4869, ENSG00000181163, P06748, B23, MGC104254
31 results:

  • 1. Nuclear PLD1 combined with npm1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma.
    Fu D; Yan J; Zhang Z; Liu Y; Ma X; Ding J; Yang S; Zhao R; Chang A; Gao C; Liu J; Zhao T; Wang X; Huang C; Gao S; Ma Y; Tang B; Feng Y; Wang H; Hao J
    Cancer Biol Med; 2023 Jun; 20(8):599-626. PubMed ID: 37381714
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Systematic analysis of the BET family in adrenocortical carcinoma: The expression, prognosis, gene regulation network, and regulation targets.
    Situ Y; Liang Q; Zeng Z; Chen J; Shao Z; Xu Q; Lu X; Cui Y; Zhang J; Lu L; Deng L
    Front Endocrinol (Lausanne); 2023; 14():1089531. PubMed ID: 36793283
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Dual Energy-Derived Metrics for Differentiating Adrenal Adenomas From Nonadenomas on Single-Phase Contrast-Enhanced CT.
    Loonis AT; Yu H; Glazer DI; Bay CP; Sodickson AD
    AJR Am J Roentgenol; 2023 May; 220(5):693-704. PubMed ID: 36416399
    [No Abstract]    [Full Text] [Related]  

  • 4. Glutathione peroxidase 4 inhibition induces ferroptosis and mTOR pathway suppression in thyroid cancer.
    Sekhar KR; Hanna DN; Cyr S; Baechle JJ; Kuravi S; Balusu R; Rathmell K; Baregamian N
    Sci Rep; 2022 Nov; 12(1):19396. PubMed ID: 36371529
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Immortalization-upregulated protein promotes pancreatic cancer progression by regulating npm1/FHL1-mediated cell-cycle-checkpoint protein activity.
    Luo Q; Pan Y; Fu Q; Zhang X; Zhou S; Yu P; Tian H; Liu P; Chen S; Zhang H; Qin T
    Cell Biol Toxicol; 2023 Oct; 39(5):2069-2087. PubMed ID: 35142956
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Single-cell transcriptomics reveals heterogeneous progression and EGFR activation in pancreatic adenosquamous carcinoma.
    Zhao X; Li H; Lyu S; Zhai J; Ji Z; Zhang Z; Zhang X; Liu Z; Wang H; Xu J; Fan H; Kou J; Li L; Lang R; He Q
    Int J Biol Sci; 2021; 17(10):2590-2605. PubMed ID: 34326696
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. PRMT1 promotes the tumor suppressor function of p14
    Repenning A; Happel D; Bouchard C; Meixner M; Verel-Yilmaz Y; Raifer H; Holembowski L; Krause E; Kremmer E; Feederle R; Keber CU; Lohoff M; Slater EP; Bartsch DK; Bauer UM
    EMBO J; 2021 Jul; 40(13):e106777. PubMed ID: 33999432
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. TERT Gene Fusions Characterize a Subset of Metastatic Leydig Cell Tumors.
    Kruslin B; Gatalica Z; Hes O; Skenderi F; Miettinen M; Contreras E; Xiu J; Ellis M; Florento E; Vranic S; Swensen J
    Clin Genitourin Cancer; 2021 Aug; 19(4):333-338. PubMed ID: 33741265
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Targeted Therapy in Patients with Metastatic Male Germ Cell Tumors.
    Heidenreich A; Paffenholz P; Nestler T; Tolkach Y; Pfister D
    Urol Int; 2021; 105(7-8):720-723. PubMed ID: 33730730
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Profiling of conditionally reprogrammed cell lines for in vitro chemotherapy response prediction of pancreatic cancer.
    Lee HS; Kim E; Lee J; Park SJ; Hwang HK; Park CH; Jo SY; Kang CM; Hong SM; Kang H; Jo JH; Cho IR; Chung MJ; Park JY; Park SW; Song SY; Han JM; Kim S; Bang S
    EBioMedicine; 2021 Mar; 65():103218. PubMed ID: 33639403
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Using protein microarray to identify and evaluate autoantibodies to tumor-associated antigens in ovarian cancer.
    Ma Y; Wang X; Qiu C; Qin J; Wang K; Sun G; Jiang D; Li J; Wang L; Shi J; Wang P; Ye H; Dai L; Jiang BH; Zhang J
    Cancer Sci; 2021 Feb; 112(2):537-549. PubMed ID: 33185955
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Nucleolin and nucleophosmin expression in seminomas and non-seminomatous testicular tumors.
    Masiuk M; Lewandowska M; Teresinski L; Dobak E; Urasinska E
    Folia Histochem Cytobiol; 2019; 57(3):139-145. PubMed ID: 31513277
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Expression of CD24 in plasma, exosome and ovarian tissue samples of serous ovarian cancer patients.
    Soltész B; Lukács J; Szilágyi E; Márton É; Szilágyi Bónizs M; Penyige A; Póka R; Nagy B
    J Biotechnol; 2019 Jun; 298():16-20. PubMed ID: 30959137
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A novel long non-coding RNA from NBL2 pericentromeric macrosatellite forms a perinucleolar aggregate structure in colon cancer.
    Dumbovic G; Biayna J; Banús J; Samuelsson J; Roth A; Diederichs S; Alonso S; Buschbeck M; Perucho M; Forcales SV
    Nucleic Acids Res; 2018 Jun; 46(11):5504-5524. PubMed ID: 29912433
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The expression profile and prognostic value of APE/Ref-1 and npm1 in high-grade serous ovarian adenocarcinoma.
    Fan X; Wen L; Li Y; Lou L; Liu W; Zhang J
    APMIS; 2017 Oct; 125(10):857-862. PubMed ID: 28766835
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Serum autoantibodies against a panel of 15 tumor-associated antigens in the detection of ovarian cancer.
    Sun H; Shi JX; Zhang HF; Xing MT; Li P; Dai LP; Luo CL; Wang X; Wang P; Ye H; Li LX; Zhang JY
    Tumour Biol; 2017 Jun; 39(6):1010428317699132. PubMed ID: 28618923
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A Comparison of Cell-Free DNA Isolation Kits: Isolation and Quantification of Cell-Free DNA in Plasma.
    Sorber L; Zwaenepoel K; Deschoolmeester V; Roeyen G; Lardon F; Rolfo C; Pauwels P
    J Mol Diagn; 2017 Jan; 19(1):162-168. PubMed ID: 27865784
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. npm1 activates metabolic changes by inhibiting FBP1 while promoting the tumorigenicity of pancreatic cancer cells.
    Zhu Y; Shi M; Chen H; Gu J; Zhang J; Shen B; Deng X; Xie J; Zhan X; Peng C
    Oncotarget; 2015 Aug; 6(25):21443-51. PubMed ID: 26068981
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. AKT regulates npm dependent ARF localization and p53mut stability in tumors.
    Hamilton G; Abraham AG; Morton J; Sampson O; Pefani DE; Khoronenkova S; Grawenda A; Papaspyropoulos A; Jamieson N; McKay C; Sansom O; Dianov GL; O'Neill E
    Oncotarget; 2014 Aug; 5(15):6142-67. PubMed ID: 25071014
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Expression and prognostic significance of APE1/Ref-1 and npm1 proteins in high-grade ovarian serous cancer.
    Londero AP; Orsaria M; Tell G; Marzinotto S; Capodicasa V; Poletto M; Vascotto C; Sacco C; Mariuzzi L
    Am J Clin Pathol; 2014 Mar; 141(3):404-14. PubMed ID: 24515769
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.